Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease

The current concept of healthcare incites a more personalized treatment of diseases. To this aim, biomarkers are needed to improve decision-making facing chronic kidney disease (CKD) patients. Prognostic markers provided by real-world (observational) evidence are proposed in this Special Issue entit...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera-Gómez, Francisco, Álvarez, F. Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145653/
https://www.ncbi.nlm.nih.gov/pubmed/33946653
http://dx.doi.org/10.3390/biomedicines9050488
Descripción
Sumario:The current concept of healthcare incites a more personalized treatment of diseases. To this aim, biomarkers are needed to improve decision-making facing chronic kidney disease (CKD) patients. Prognostic markers provided by real-world (observational) evidence are proposed in this Special Issue entitled “Biomarkers in Chronic Kidney Disease”, with the intention to identify high-risk patients. These markers do not target measurable parameters in patients but clinical endpoints that may be in turn transformed to benefits under the effect of future interventions.

Ejemplares similares